Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.

Standard

Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. / Kirchhof, P; Nabauer, M; Gerth, A; Limbourg, T; Lewalter, T; Goette, A; Wegscheider, Karl; Treszl, András; Meinertz, Thomas; Oeff, M; Ravens, U; Breithardt, G; Steinbeck, G; Investigators, AFNET Registry.

in: THROMB HAEMOSTASIS, Jahrgang 105, Nr. 6, 6, 2011, S. 1010-1023.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Kirchhof, P, Nabauer, M, Gerth, A, Limbourg, T, Lewalter, T, Goette, A, Wegscheider, K, Treszl, A, Meinertz, T, Oeff, M, Ravens, U, Breithardt, G, Steinbeck, G & Investigators, AFNETR 2011, 'Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.', THROMB HAEMOSTASIS, Jg. 105, Nr. 6, 6, S. 1010-1023. <http://www.ncbi.nlm.nih.gov/pubmed/21544322?dopt=Citation>

APA

Kirchhof, P., Nabauer, M., Gerth, A., Limbourg, T., Lewalter, T., Goette, A., Wegscheider, K., Treszl, A., Meinertz, T., Oeff, M., Ravens, U., Breithardt, G., Steinbeck, G., & Investigators, AFNET. R. (2011). Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. THROMB HAEMOSTASIS, 105(6), 1010-1023. [6]. http://www.ncbi.nlm.nih.gov/pubmed/21544322?dopt=Citation

Vancouver

Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A et al. Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. THROMB HAEMOSTASIS. 2011;105(6):1010-1023. 6.

Bibtex

@article{cfd772fe168c499a92ef6e0c0098b201,
title = "Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.",
abstract = "Atrial fibrillation (AF) patients may receive treatment from specialists or from general medicine physicians representing different levels of care within a structured health care system. This {"}choice{"} is influenced by patient flow within a health care system, patient preference, and individual access to health care resources. We analysed how the postgraduate training and work environment of treating physicians affects management decisions in AF patients. Patient characteristics and treatment decisions were analysed at the time of enrolment into the registry of the German Atrial Fibrillation NETwork (AFNET). A total of 9,577 patients were enrolled from 2004 to 2006 in 191 German centres that belonged to the following four levels of care: 13 tertiary care centres (TCC) enrolled 3,795 patients (39.6%), 58 district hospitals (DH) enrolled 2,339 patients (24.4%), 62 office-based cardiologists (OC) enrolled 2,640 patients (27.6%), and 58 general practitioners or internists (GP) enrolled 803 patients (8.4%). Patients with new-onset AF were often treated in DH. TCC treated younger patients who more often presented with paroxysmal AF. Older patients and patients in permanent AF more often received outpatient care. Consistent with recommendations, younger patients and patients with non-permanent AF received rhythm control therapy more often. In addition, the type of centre affected the decision for rhythm control. Stroke risk was similar between centre types (mean CHADS2 scores 1.6 -1.9). TCC (68.8%) and OC (73.6%) administered adequate antithrombotic therapy more often than DH (55.1%) or GP (52.0%, p",
keywords = "Germany, Humans, Registries, Disease Progression, Physician's Practice Patterns, Recurrence, Fibrinolytic Agents/*therapeutic use, Ambulatory Care/statistics & numerical data, Hospitals, Atrial Fibrillation/*epidemiology/physiopathology/*therapy, *Cardiology, Education, Medical, Graduate, General Practitioners, Health Services Accessibility/standards, Professional Practice/*statistics & numerical data, Germany, Humans, Registries, Disease Progression, Physician's Practice Patterns, Recurrence, Fibrinolytic Agents/*therapeutic use, Ambulatory Care/statistics & numerical data, Hospitals, Atrial Fibrillation/*epidemiology/physiopathology/*therapy, *Cardiology, Education, Medical, Graduate, General Practitioners, Health Services Accessibility/standards, Professional Practice/*statistics & numerical data",
author = "P Kirchhof and M Nabauer and A Gerth and T Limbourg and T Lewalter and A Goette and Karl Wegscheider and Andr{\'a}s Treszl and Thomas Meinertz and M Oeff and U Ravens and G Breithardt and G Steinbeck and Investigators, {AFNET Registry}",
year = "2011",
language = "English",
volume = "105",
pages = "1010--1023",
journal = "THROMB HAEMOSTASIS",
issn = "0340-6245",
publisher = "Schattauer",
number = "6",

}

RIS

TY - JOUR

T1 - Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions.

AU - Kirchhof, P

AU - Nabauer, M

AU - Gerth, A

AU - Limbourg, T

AU - Lewalter, T

AU - Goette, A

AU - Wegscheider, Karl

AU - Treszl, András

AU - Meinertz, Thomas

AU - Oeff, M

AU - Ravens, U

AU - Breithardt, G

AU - Steinbeck, G

AU - Investigators, AFNET Registry

PY - 2011

Y1 - 2011

N2 - Atrial fibrillation (AF) patients may receive treatment from specialists or from general medicine physicians representing different levels of care within a structured health care system. This "choice" is influenced by patient flow within a health care system, patient preference, and individual access to health care resources. We analysed how the postgraduate training and work environment of treating physicians affects management decisions in AF patients. Patient characteristics and treatment decisions were analysed at the time of enrolment into the registry of the German Atrial Fibrillation NETwork (AFNET). A total of 9,577 patients were enrolled from 2004 to 2006 in 191 German centres that belonged to the following four levels of care: 13 tertiary care centres (TCC) enrolled 3,795 patients (39.6%), 58 district hospitals (DH) enrolled 2,339 patients (24.4%), 62 office-based cardiologists (OC) enrolled 2,640 patients (27.6%), and 58 general practitioners or internists (GP) enrolled 803 patients (8.4%). Patients with new-onset AF were often treated in DH. TCC treated younger patients who more often presented with paroxysmal AF. Older patients and patients in permanent AF more often received outpatient care. Consistent with recommendations, younger patients and patients with non-permanent AF received rhythm control therapy more often. In addition, the type of centre affected the decision for rhythm control. Stroke risk was similar between centre types (mean CHADS2 scores 1.6 -1.9). TCC (68.8%) and OC (73.6%) administered adequate antithrombotic therapy more often than DH (55.1%) or GP (52.0%, p

AB - Atrial fibrillation (AF) patients may receive treatment from specialists or from general medicine physicians representing different levels of care within a structured health care system. This "choice" is influenced by patient flow within a health care system, patient preference, and individual access to health care resources. We analysed how the postgraduate training and work environment of treating physicians affects management decisions in AF patients. Patient characteristics and treatment decisions were analysed at the time of enrolment into the registry of the German Atrial Fibrillation NETwork (AFNET). A total of 9,577 patients were enrolled from 2004 to 2006 in 191 German centres that belonged to the following four levels of care: 13 tertiary care centres (TCC) enrolled 3,795 patients (39.6%), 58 district hospitals (DH) enrolled 2,339 patients (24.4%), 62 office-based cardiologists (OC) enrolled 2,640 patients (27.6%), and 58 general practitioners or internists (GP) enrolled 803 patients (8.4%). Patients with new-onset AF were often treated in DH. TCC treated younger patients who more often presented with paroxysmal AF. Older patients and patients in permanent AF more often received outpatient care. Consistent with recommendations, younger patients and patients with non-permanent AF received rhythm control therapy more often. In addition, the type of centre affected the decision for rhythm control. Stroke risk was similar between centre types (mean CHADS2 scores 1.6 -1.9). TCC (68.8%) and OC (73.6%) administered adequate antithrombotic therapy more often than DH (55.1%) or GP (52.0%, p

KW - Germany

KW - Humans

KW - Registries

KW - Disease Progression

KW - Physician's Practice Patterns

KW - Recurrence

KW - Fibrinolytic Agents/therapeutic use

KW - Ambulatory Care/statistics & numerical data

KW - Hospitals

KW - Atrial Fibrillation/epidemiology/physiopathology/therapy

KW - Cardiology

KW - Education, Medical, Graduate

KW - General Practitioners

KW - Health Services Accessibility/standards

KW - Professional Practice/statistics & numerical data

KW - Germany

KW - Humans

KW - Registries

KW - Disease Progression

KW - Physician's Practice Patterns

KW - Recurrence

KW - Fibrinolytic Agents/therapeutic use

KW - Ambulatory Care/statistics & numerical data

KW - Hospitals

KW - Atrial Fibrillation/epidemiology/physiopathology/therapy

KW - Cardiology

KW - Education, Medical, Graduate

KW - General Practitioners

KW - Health Services Accessibility/standards

KW - Professional Practice/statistics & numerical data

M3 - SCORING: Journal article

VL - 105

SP - 1010

EP - 1023

JO - THROMB HAEMOSTASIS

JF - THROMB HAEMOSTASIS

SN - 0340-6245

IS - 6

M1 - 6

ER -